Advanced in Pulmonary Tuberculosis

Frederic Mechai

Paris, FR 
Advanced in Pulmonary Tuberculosis
Paris, FR 
OverviewLocationsClinical Research

Overview

Frederic Mechai practices in Paris, France. Mr. Mechai is rated as an Advanced expert by MediFind in the treatment of Pulmonary Tuberculosis. His top areas of expertise are Pulmonary Tuberculosis, Meningitis, Endocarditis, and HIV/AIDS.

His clinical research consists of co-authoring 64 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Pulmonary Tuberculosis.

Gender
Male

Locations

Paris, France
Other Locations
Bobigny, France
Saint Mandé, France
rue la milétrie
Poitiers, 86021, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus (Relais Oral Dans le Traitement Des Endocardites à Staphylocoques Multi-sensibles)
Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus (Relais Oral Dans le Traitement Des Endocardites à Staphylocoques Multi-sensibles)
Enrollment Status: Unknown
Publish Date: May 19, 2021
Intervention Type: Procedure, Drug
Study Drugs: Levofloxacin, Rifampicin
Study Phase: Phase 3
Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus (Relais Oral Dans le Traitement Des Endocardites à Streptocoques Multi-sensibles)
Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus (Relais Oral Dans le Traitement Des Endocardites à Streptocoques Multi-sensibles)
Enrollment Status: Unknown
Publish Date: May 19, 2021
Intervention Type: Procedure, Drug
Study Drug: Amoxicillin
Study Phase: Phase 3
Early Oral Switch Therapy in Low-risk Staphylococcus Aureus Bloodstream Infection
Early Oral Switch Therapy in Low-risk Staphylococcus Aureus Bloodstream Infection
Enrollment Status: Completed
Publish Date: May 27, 2020
Intervention Type: Drug
Study Phase: Phase 3
Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae
Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae
Enrollment Status: Unknown
Publish Date: June 06, 2018
Intervention Type: Drug
Study Drug: Temocillin
Study Phase: Phase 4
View 3 Less Clinical Trials

64 Total Publications

Levofloxacin in Bone and Joint Infections: Development of an Application for Model-Informed Precision Dosing.
Levofloxacin in Bone and Joint Infections: Development of an Application for Model-Informed Precision Dosing.
Journal: Clinical pharmacology and therapeutics
Published: April 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Mechai's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile